Esophageal Squamous Cell Carcinoma
2 stories
-
healthToripalimab Extends Survival in Nasopharyngeal and Esophageal Cancers
Phase III trials JUPITER-02 and JUPITER-06 show toripalimab combined with chemotherapy significantly improves overall survival for nasopharyngeal and esophageal squamous cell carcinoma patients.
-
healthSmoking Dominates Esophageal Cancer Risk, Study Finds
Johannesburg analysis reveals smoking as the primary modifiable risk factor for esophageal squamous cell carcinoma, significantly outweighing alcohol consumption.